Comparison of the renoprotective effects of angiotensin converting enzyme inhibitors and angiotensinⅡ receptor blockers in patients with renal failure

• In: Pharmacy Information Section Posters
• At: New Orleans (USA) (2004)
• Type: Poster
• Poster code: PI-P007
• By: IIDA, Emiko (Chiba University, Graduate School of Pharm. Sience, Chiba City, Japan)
• Co-author(s): Tajima (Chiba University, CHIBA CITY, Japan)
  Terajima (Chiba University, CHIBA CITY, Japan)
  Iesato (Chiba Social Insurance Hospital, Japan)
  Yoshida (San-ai Memorial Hospital, Japan)
  Irie (San-ai Memorial Hospital, Japan)
  Ogawa (Chiba University Hospital, Japan)
  Yamagata (Chiba University, CHIBA CITY, Japan)
  Satoh (Chiba University, CHIBA CITY, Japan)
  Ueda (Chiba University, CHIBA CITY, Japan)
  
• Abstract:

  Background: It was reported that treatment with angiotensin converting
  
  enzyme inhibitors (ACEIs) provides benefits for patients with renal
  
  failure by suppressing the progression of renal failure. Though
  
  angiotensin receptor blockers(ARBs) are expected to have same or
  
  more effects than ACEIs, its effects are not established. The objective
  
  of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login